Does Dr. ROBIN ABDELMALIK have financial conflicts of interest?

Dr. ROBIN ABDELMALIK (M.D. FACC) has received a total of $6,904 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $6,904 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ROBIN ABDELMALIK?

According to CMS Open Payments data, Dr. ROBIN ABDELMALIK received funding from ABBOTT LABORATORIES ($929), NOVARTIS PHARMACEUTICALS CORPORATION ($630), and ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($530).

Does Dr. ROBIN ABDELMALIK receive research grants or speaking fees?

Dr. ROBIN ABDELMALIK has received $6,904 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ROBIN ABDELMALIK

M.D. FACCReal-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: TEMECULA, CA 92592

NPI Number: 1275656662

LIFETIME INDUSTRY VALUE

$6,904

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDELMALIK is a verified Internal Medicine, Cardiovascular Disease practitioner based in TEMECULA, CA.

Between 2021 and 2024, Dr. ABDELMALIK had an overall industry promotional and research financial footprint of $6,904 as recorded in the federal CMS Open Payments database.

$6,904 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDELMALIK's primary funding source is ABBOTT LABORATORIES, which accounts for $929 (representing 13.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBOTT LABORATORIES

Rank 1

$929

13.5%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 2

$630

9.1%

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 3

$530

7.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.